MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/600/0.01/20.06.25 Share Price

Warrant

DE000MB7W946

Market Closed - Börse Stuttgart 09:58:16 27/06/2024 pm IST
0.32 EUR +3.23% Intraday chart for MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/600/0.01/20.06.25
Current month+3.23%
1 month-8.57%
Date Price Change
27/24/27 0.32 +3.23%
26/24/26 0.31 +14.81%
25/24/25 0.27 -10.00%
24/24/24 0.3 +7.14%
21/24/21 0.28 0.00%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 09:58 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
Issuer Morgan Stanley
WKN MB7W94
ISINDE000MB7W946
Date issued 26/06/2023
Strike 600 $
Maturity 20/06/2025 (358 Days)
Parity 100 : 1
Emission price 0.71
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.25
Lowest since issue 0.2
Delta0.39x
Omega 5.337
Premium28.73x
Gearing13.77x
Moneyness 0.8233
Difference Strike 106 $
Difference Strike %+17.67%
Spread 0.03
Spread %8.57%
Theoretical value 0.3350
Implied Volatility 31.89 %
Total Loss Probability 72.64 %
Intrinsic value 0.000000
Present value 0.3350
Break even 635.86 €
Theta-0.01x
Vega0.02x
Rho0.01x

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
494 USD
Average target price
564.1 USD
Spread / Average Target
+14.21%
Consensus